MaasA.I.R., MarmarouA., MurrayG.D.Prognosis and clinical trial design in traumatic brain injury: the IMPACT study.J Neurotrauma2007; 24: 232–8.
2.
MenonD.K., ZahedC.Prediction of outcome in severe traumatic brain injury.Curr Opin Crit Care2009; 15: 437–41.
3.
HesdorfferD.C., GhajarJ.Marked improvement in adherence to traumatic brain injury guidelines in United States trauma center.J Trauma2007; 63: 841–7.
4.
ArbabiS., AhrnsK.S., WahlW.L.Beta-blocker use is associated with improved outcomes in adult burn patients.J Trauma2004; 56: 265–71.
5.
CottonB.A., SnodgrassK.B., FlemingS.B.Beta-blocker exposure is associated with improved survival after severe traumatic brain injury.J Trauma2007; 62: 26–33.
6.
InabaK., TeixeiraP.G., DavidJ.S.Beta-blockers in isolated blunt head injury.J Am Coll Surg2008; 206: 432–8.
7.
RiordanW.P.Jr., CottonB.A., NorrisP.R.Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling.J Trauma2007; 63: 503–10.
8.
SalimA., HadijizachariaP., BrownC.Significance of troponin elevation after severe traumatic brain injury.J Trauma2008; 64: 46–52.
9.
CliftonG.L., ZieglerM.G., GrossmanR.G.Circulating catecholamines and sympathetic activity after head injury.Neurosurgery1981; 8: 10–4.
MautesA.E.M., MullerM., CortbusF.Alterations of norepinephrine levels in plasma and CSF of patients after traumatic brain injury in relation to disruption of the blood-brain barrier.Acta Neurochir (Wien)2001; 143: 51–8.
12.
WoolfP.D., HamillR.W., LeeL.A.Evaluation of the dopamine response to stress in man.J Clin Endocrinol Metab1983; 56: 246–50.
13.
WoolfP.D., HamillR.W., LeeL.A.The predictive value of catecholamines in assessing outcome in traumatic brain injury.J Neurosurg1987; 66: 875–82.
14.
WoolfP.D., HamillR.W., LeeL.A.Free and total catecholamines in critical illness.Am J Physiol1988; 254(3 Pt 1): E287–91.
15.
CliftonG.L., ZieglerM.G., GrossmanR.G.Circulating catecholamines and sympathetic activity after head injury.Neurosurgery1981; 8: 10–4.
16.
FrieseR.S., BarberR., McBrideD.Could beta blockade improve outcome after injury by modulating inflammatory profiles?J Trauma2008; 64: 1061–8.
17.
Morganti-KossmannM.C., SatgunaseelanL., ByeN.Modulation of immune response by head injury.Injury2007; 38: 1392–400.
18.
NordstromC.H., MesseterK., SundbargG.Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions.J Neurosurg1988; 68: 424–31.
19.
SeekampA., JochumM., ZieglerM.Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion.J Trauma1998; 44: 874–82.
20.
WalterP., Neil-DwyerG., CruickshankJ.M.Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage.Br Med J (Clin Res Ed)1982; 284: 1661–4.
21.
WoolfP.D., HamillR.W., LeeL.A.The predictive value of catecholamines in assessing outcome in traumatic brain injury.J Neurosurg1987; 66: 875–82.
22.
ManganoD.T., LayugE.L., WallaceA.Effect of atenolol on mortality and cardiovascular morbidity and noncardiac surgery.N Engl J Med1996; 335: 1713–20.
23.
BouriS., Shun-ShinM.J., ColeG.D.Meta-analysis of secure randomized controlled trials of B-blockade to prevent perioperative death in non-cardiac surgery.Heart2014; 100(Suppl 6): 456–64.
24.
AsgeirssonB., GrandeP.O., NordstromC.H.Effects of hypotensive treatment with alpha 2-agonist and beta 1-antagonist on cerebral haemodynamics in severely head injured patients.Acta Anaesthesiol Scand1995; 39: 347–51.
25.
NeideenT., LamM., BraselK.Preinjury beta-blockers are associated with increased mortality in geriatric trauma patients.J Trauma2008; 65: 1016–20.
26.
SchmitzD., WilsenackK., LendemannsS.Beta-adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of s epsis.Resuscitation2007; 72: 286–94.
